Inpatient therapeutic options

Patients with acute dyspnea resulting from acute heart failure should be rapidly assessed and stabilized. First, patients should be put in a seated posture and, if necessary, supplemental oxygen and ventilatory support (noninvasive or invasive, see below) should be provided [1]. After that, therapeu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kreußer, Michael (VerfasserIn) , Raake, Philip (VerfasserIn)
Dokumenttyp: Kapitel/Artikel
Sprache:Englisch
Veröffentlicht: 2019
In: Heart failure
Year: 2019, Pages: 165-170
DOI:10.1007/978-3-319-98184-0_11
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/978-3-319-98184-0_11
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/chapter/10.1007/978-3-319-98184-0_11
Volltext
Verfasserangaben:Michael M. Kreusser and Philip W. Raake

MARC

LEADER 00000caa a2200000 c 4500
001 1906645825
003 DE-627
005 20241205182553.0
007 cr uuu---uuuuu
008 241023s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/978-3-319-98184-0_11  |2 doi 
035 |a (DE-627)1906645825 
035 |a (DE-599)KXP1906645825 
035 |a (OCoLC)1475316701 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kreußer, Michael  |d 1980-  |e VerfasserIn  |0 (DE-588)132382385  |0 (DE-627)521949424  |0 (DE-576)260798495  |4 aut 
245 1 0 |a Inpatient therapeutic options  |c Michael M. Kreusser and Philip W. Raake 
264 1 |c 2019 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.10.2024 
520 |a Patients with acute dyspnea resulting from acute heart failure should be rapidly assessed and stabilized. First, patients should be put in a seated posture and, if necessary, supplemental oxygen and ventilatory support (noninvasive or invasive, see below) should be provided [1]. After that, therapeutic aims should be focused on the correction of hemodynamic and intravascular volume abnormalities. Therapy has to be tailored to the individual situation, however, diuretics are the mainstay of therapy in the acute setting. Early intravenous vasodilator therapy is important for selected patients with the need of targeting systemic vascular resistance and left ventricular overload. This includes patients with severe hypertension, acute mitral regurgitation, or acute aortic regurgitation. The patient’s hemodynamic and volume status determines how aggressive diuretic and vasodilator therapy has to be initiated. Acute heart failure therapy may be guided differentially in three stages of treatment: urgent/emergent care, hospitalization, and pre-discharge [2]. Therapies can be necessary to be used during any of these stages and are discussed in the following in detail. Monitoring and diagnostics in acute heart failure are discussed above. 
700 1 |a Raake, Philip  |d 1975-  |e VerfasserIn  |0 (DE-588)129151246  |0 (DE-627)390021725  |0 (DE-576)297510568  |4 aut 
773 0 8 |i Enthalten in  |t Heart failure  |d Cham : Springer, 2019  |g (2019), Seite 165-170  |h 1 Online-Ressource (IX, 328 Seiten)  |w (DE-627)1067369341  |w (DE-576)518432556  |z 9783319981840  |7 nnam  |a Inpatient therapeutic options 
773 1 8 |g year:2019  |g pages:165-170  |g extent:6  |a Inpatient therapeutic options 
856 4 0 |u https://doi.org/10.1007/978-3-319-98184-0_11  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://link.springer.com/chapter/10.1007/978-3-319-98184-0_11  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20241023 
993 |a BookComponentPart 
994 |a 2019 
998 |g 129151246  |a Raake, Philip  |m 129151246:Raake, Philip  |d 910000  |d 910100  |d 50000  |e 910000PR129151246  |e 910100PR129151246  |e 50000PR129151246  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 2  |y j 
998 |g 132382385  |a Kreußer, Michael  |m 132382385:Kreußer, Michael  |d 910000  |d 910100  |d 50000  |e 910000PK132382385  |e 910100PK132382385  |e 50000PK132382385  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1906645825  |e 460163797X 
BIB |a Y 
JSO |a {"relHost":[{"part":{"year":"2019","pages":"165-170","text":"(2019), Seite 165-170","extent":"6"},"recId":"1067369341","language":["eng"],"disp":"Inpatient therapeutic optionsHeart failure","type":{"media":"Online-Ressource","bibl":"edited-book"},"title":[{"title":"Heart failure","title_sort":"Heart failure"}],"person":[{"roleDisplay":"HerausgeberIn","display":"Feldman, David S.","role":"edt","family":"Feldman","given":"David S."},{"family":"Mohacsi","given":"Paul","roleDisplay":"HerausgeberIn","display":"Mohacsi, Paul","role":"edt"}],"physDesc":[{"extent":"1 Online-Ressource (IX, 328 Seiten)","noteIll":"Illustrationen, Diagramme"}],"id":{"isbn":["9783319981840"],"eki":["1067369341"],"doi":["10.1007/978-3-319-98184-0"]},"origin":[{"dateIssuedKey":"2019","publisher":"Springer","dateIssuedDisp":"[2019]","publisherPlace":"Cham ; Switzerland"}],"name":{"displayForm":["David S. Feldman, Paul Mohacsi, editors"]}}],"physDesc":[{"extent":"6 S."}],"id":{"eki":["1906645825"],"doi":["10.1007/978-3-319-98184-0_11"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"name":{"displayForm":["Michael M. Kreusser and Philip W. Raake"]},"language":["eng"],"recId":"1906645825","note":["Gesehen am 23.10.2024"],"type":{"media":"Online-Ressource","bibl":"chapter"},"title":[{"title_sort":"Inpatient therapeutic options","title":"Inpatient therapeutic options"}],"person":[{"family":"Kreußer","given":"Michael","display":"Kreußer, Michael","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Raake, Philip","given":"Philip","family":"Raake"}]} 
SRT |a KREUSSERMIINPATIENTT2019